Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19

Future Oncol. 2020 Jul;16(20):1409-1411. doi: 10.2217/fon-2020-0388. Epub 2020 May 14.
No abstract available

Keywords: ADT; COVID-19; androgen deprivation therapy; cancer; hormonal therapy; prostate; prostatectomy; surgery; urologic.

Publication types

  • Editorial

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections / pathology
  • Coronavirus Infections / therapy*
  • Equipment and Supplies, Hospital / supply & distribution*
  • Hospitals / supply & distribution
  • Humans
  • Male
  • Pandemics
  • Pneumonia, Viral / pathology
  • Pneumonia, Viral / therapy*
  • Prostatectomy
  • Prostatic Neoplasms / therapy*
  • SARS-CoV-2
  • Time-to-Treatment*
  • Watchful Waiting / statistics & numerical data*

Substances

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal